BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

IGI’s Trispecific Antibody ISB 2001 Receives FDA Fast Track Designation for Relapsed Multiple Myeloma

IGI, a global, fully integrated, clinical-stage biotechnology company focused on multi-species™ oncology product development, announced that th...

May 06, 2025 | News

Genocury Biotech’s In Vivo CD19 CAR-T Achieves Complete Remission in R/R DLBCL Without Lymphodepletion

Genocury Biotech today revealed groundbreaking clinical data from its noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large ...

May 01, 2025 | News

Gene Solutions and Element Biosciences Forge Multiomics Collaboration to Expand Access to Genetic Testing Across Asia and Beyond

Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing acc...

April 23, 2025 | News

VelaVigo Bio Signs $440M Global Licensing Deal with Ollin Biosciences for First-in-Class Bispecific Antibody VBS-102

VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specif...

April 18, 2025 | News

Saudi Arabia and France Sign Strategic Agreements to Boost Collaboration in Biotech and Digital Health

Saudi Arabia and France have signed strategic agreements focusing on biotechnology and digital health. These partnerships aim to accelerate innovation, imp...

April 17, 2025 | News

Atmo Biosciences Secures Full Ownership of Core IP for Ingestible Gas-Sensing Capsule

Atmo secures full ownership of core IP for its ingestible gas-sensing capsule • RMIT University transfers all patents and IP in exchange for an eq...

April 15, 2025 | News

Chromatin Bioscience Partners with Astellas to Advance Cell-Selective Gene Expression Technologies

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with As...

April 15, 2025 | News

Thermo Fisher Scientific and NSG BIO Join Forces to Boost Singapore’s Biotech Innovation

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth Thermo Fisher Sc...

April 09, 2025 | News

Singapore’s Engine Biosciences and EDDC Launch First-Ever Partnership to Advance Precision Cancer Therapies

This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC),&nb...

April 08, 2025 | News

PeptiGrowth to Launch Synthetic KGF Alternative Peptide PG-012 in April 2025 for Regenerative Medicine Applications

PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KG...

April 02, 2025 | News

Yingli Pharma Receives FDA Clearance to Launch Global Phase 3 Trial of Linperlisib for Relapsed/Refractory PTCL

Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic...

April 02, 2025 | News

IASO Bio Secures First Approval Outside Mainland China for Equecabtagene Autoleucel in Macau

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative ce...

March 31, 2025 | News

Gene Solutions Achieves Landmark Validation for Asia’s First Clinically Proven Multi-Cancer Blood Test, SPOT-MAS

Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. Common cance...

March 27, 2025 | News

AnHorn Medicines Doses First Subject in U.S. Phase I Trial for AH-001, a First-in-Class Protein Degrader Targeting Hair Loss

AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androg...

March 27, 2025 | News

Stay Connected